Philip Collier

About Philip Collier

Medicinal chemist with broad experience in drug discovery spanning from target selection & validation through clinical candidate nomination- Co-invented and delivered multiple clinical and pre-clinical drug candidates. Effectively led cross functional teams and drove programs to key milestones- Critical and strategic thinker, delivering innovative solutions in complex settings on tight timelines. Deep knowledge across multiple therapeutic areas, including immunology, oncology, anti-infectives, respiratory, neurodegenerative, neuromuscular and rare diseases- Proven leader, experience of building and developing highly effective teams, including recruiting and mentoring; passionate about developing the next generation of leaders- Excellent knowledge of modern drug discovery technologies, new modalities (TPD, RNA-targeting) and in disciplines outside core area expertise (protein sciences, pharmacology, DMPK, toxicology, CMC, IP filing)- 50+ peer reviewed articles and patents, and frequent presenting and chairing at external meetings. Experience establishing/fostering external collaborations with CROs and academia.

Experience

1. Senior Principal Scientist Ii, Lab Head Medicinal Chemistry

   Sanofi

   Aug 2025 — Present · Cambridge, MA, US

Education

• University of York

  PhD, Organic Chemistry

• University College Cork

  BSc, First Class Honours, Chemistry

Skills

• Inorganic Chemistry
• Medicinal Chemistry
• Kinases
• Lead Change
• High-Performance Liquid Chromatography (Hplc)
• Drug Development
• Cancer
• Biotechnology
• Organometallic Chemistry
• Drug Design
• Immunology
• Chemistry
• Patents
• Organic Chemistry
• Drug Discovery
• Organic Synthesis
• Pharmaceutical Industry
• Lc-Ms
• Life Sciences
• Oncology
• Chromatography
• Dmpk